StonvexLoading…
StonvexStonvexStonvexCore line items from AACG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $38.34M | $36.72M | $31.21M | $29.99M |
Operating Income | $-9.17M | $-5.90M | $-5.84M | $-8.20M |
Net Income | $-6.87M | $-4.95M | $-4.74M | $-6.94M |
EPS (Diluted) | $-0.11 | $-0.08 | $-0.08 | $-0.11 |
Total Assets | $58.39M | $62.60M | $63.23M | $68.79M |
Total Liabilities | $53.81M | $51.69M | $47.32M | $47.98M |
Cash & Equivalents | $12.19M | $5.00M | $8.47M | $7.97M |
Free Cash Flow OCF − CapEx | $-2.45M | $-3.20M | $917.11K | $-2.35M |
Shares Outstanding | 63.59M | 63.25M | 62.89M | 62.75M |